Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loeb, C.
Right arrow Articles by Gandolfo, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loeb, C.
Right arrow Articles by Gandolfo, C.

Stroke, Vol 14, 399-401, Copyright © 1983 by American Heart Association


ARTICLES

Diagnostic evaluation of degenerative and vascular dementia

C Loeb and C Gandolfo

The accuracy of the Ischemic Score (IS) of Hachinski in the differential diagnosis between senile dementia (SDAT) and multi-infarct dementia (MID) is evaluated in this study. Ninety-four demented patients were subdivided on the basis of CT scan in three subgroups: 1) CT-SDAT (ventricular enlargement and widening of cortical sulci), 2) CT- MID (multiple low density areas attributable to ischemic lesions), 3) CT-VASC (single low density area attributable to ischemic lesion). Sixty-nine percent of patients with SDAT and 94% of patients with MID had an Ischemic Score in agreement with the diagnosis established by CT scan. With the purpose of improving the accuracy of the I.S., a modified ischemic score consisting of five items (abrupt onset; history of strokes; focal symptoms; focal signs; focal (single or multiple) CT- low density areas) is proposed as a useful tool in the differential diagnosis between SDAT and MID.


This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
C. Capurso, V. Solfrizzi, A. D'Introno, A. M. Colacicco, S. A. Capurso, F. Mastroianni, M. Liaci, G. Vendemiale, A. Capurso, and F. Panza
The Cathepsin D Gene Exon 2 (C224T) Polymorphism and Sporadic Alzheimer's Disease in European Populations
J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2005; 60(8): 991 - 996.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. Quadri, C. Fragiacomo, R. Pezzati, E. Zanda, G. Forloni, M. Tettamanti, and U. Lucca
Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 114 - 122.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. Chetelat, B. Desgranges, V. de la Sayette, F. Viader, K. Berkouk, B. Landeau, C. Lalevee, F. Le Doze, B. Dupuy, D. Hannequin, et al.
Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment
Brain, September 1, 2003; 126(9): 1955 - 1967.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
F. Forette, M.-L. Seux, J. A. Staessen, L. Thijs, M.-R. Babarskiene, S. Babeanu, A. Bossini, R. Fagard, B. Gil-Extremera, T. Laks, et al.
The Prevention of Dementia With Antihypertensive Treatment: New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study
Arch Intern Med, October 14, 2002; 162(18): 2046 - 2052.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J.-M. Orgogozo, A.-S. Rigaud, A. Stoffler, H.-J. Mobius, and F. Forette
Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia: A Randomized, Placebo-Controlled Trial (MMM 300)
Stroke, July 1, 2002; 33(7): 1834 - 1839.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
V Solfrizzi, F Panza, A D'Introno, A M Colacicco, C Capurso, A M Basile, and A Capurso
Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 732 - 736.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
V. Solfrizzi, F. Panza, F. Torres, C. Capurso, A. D'Introno, A. M. Colacicco, and A. Capurso
Selective Attention Skills in Differentiating between Alzheimer's Disease and Normal Aging
J Geriatr Psychiatry Neurol, June 1, 2002; 15(2): 99 - 109.
[Abstract] [PDF]


Home page
Arch NeurolHome page
H. C. Chui, W. Mack, J. E. Jackson, D. Mungas, B. R. Reed, J. Tinklenberg, F.-L. Chang, K. Skinner, C. Tasaki, and W. J. Jagust
Clinical Criteria for the Diagnosis of Vascular Dementia: A Multicenter Study of Comparability and Interrater Reliability
Arch Neurol, February 1, 2000; 57(2): 191 - 196.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. P. Imbimbo, P. Martelli, W. M. Troetel, F. Lucchelli, U. Lucca, and L. J. Thal
Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease
Neurology, March 1, 1999; 52(4): 700 - 700.
[Abstract] [Full Text]


Home page
StrokeHome page
T. Wetterling, R.-D. Kanitz, and K.-J. Borgis
Comparison of Different Diagnostic Criteria for Vascular Dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN)
Stroke, January 1, 1996; 27(1): 30 - 36.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
K. F. Mortel, M. A. Pavol, S. Wood, J. S. Meyer, Y. Terayama, J. L. Rexer, and B. Herod
Prospective Studies of Cerebral Perfusion and Cognitive Testing Among Elderly Normal Volunteers and Patients with Ischemic Vascular Dementia and Alzheimer's Disease
Angiology, March 1, 1994; 45(3): 171 - 180.
[Abstract] [PDF]